Search results for " CDMO" in Articles / App Notes
Article
CDMOs Driving Emerging Bio/Pharma Success
For that reason, CDMOs and contract research organizations (CROs) are the real enablers of success for emerging bio/pharma companies.
By relying on CDMOs, emerging bio/pharma companies can get …
Article
The Role of CDMOs in Cell and Gene Therapy Process Development
Click here to read more >>
An experienced contract development and manufacturing organization (CDMO) can ease scaling and tech transfer.
Article
Step Up to GMP Manufacturing or Outsource to a CDMO: Considerations and Tips
Whether you are developing a new monoclonal antibody (mAb), cell therapy, gene therapy, or large-molecule biologic drug, the decision to tackle GMP manufacturing in-house or work with a contract devel…
Article
Is Not Using a CDMO Slowing Down Your Process Development?
Consider what process development capabilities you have versus what you could possibly gain from working with a CDMO to not only be successful, but also to improve your chances of getting to market …
Article
Contract Manufacturing Through the Years
In light of Pharmaceutical Technology’s 40th anniversary, it is appropriate to review the CDMO industry’s evolution and outlook.
Early days
Phase one of the CDMO industry includes the y…
Article
Maximum Output Starts with Optimized Upstream Processing
This issue is currently leading many CDMOs to reject projects or set long wait times for new customers to ensure they are able to fulfill their existing contracts, even though they may have under-util…
Article
Strategizing for Rapid Changeovers in Biologics Manufacturing
Husain, senior vice president and CDMO business unit head at Emergent BioSolutions.
Stainless-steel equipment specifically presents a common challenge, as it requires cleaning and validation of pr…
Article
Climate Change in Outsourcing
…and clinical supplies management are still in their early stages, and the larger analytical labs and CDMOs are positioning themselves for those opportunities.
Small is beautiful. Global bio/pharm…
Article
The Tide Stays High
Not surprisingly, this has been great news for CDMOs and CROs. Most publicly-traded services providers achieved revenue growth well in excess of 10% in 2016 (based on interim results), especially in t…
Article
Evolving demands of process development services
Phase-appropriate development is also often asked of many CDMOs, and this usually means running pathways sequentially. Another way timelines can be accelerated is by developing an ‘end-in-mind’ proces…